Table 4.
Univariate and Multivariate Analyses of Patients Underwent Surgery on Progression-free Survival. (n = 104).
| Characteristics | n (%) | Univariate analyses | Multivariate analyses | ||
|---|---|---|---|---|---|
| P value | HR (95% CI) | P value | HR (95% CI) | ||
| FIGO stage | .230 | ||||
| IVA | 18 | 1 | |||
| IVB | 86 | 1.482 (.780-2.816) | |||
| Metastasis pattern | |||||
| Lymph node metastasis | 11 | 1 | .357 | .656 (.267-1.610) | |
| Parenchymal metastasis | 29 | .041 | 2.458 (.982-6.151) | ||
| Multi-metastasis | 46 | .039 | 2.396 (.995-5.773) | ||
| Multi-metastasis | .082 | .162 | 1.418 (.870-2.312) | ||
| No | 57 | 1 | |||
| Yes | 46 | 1.510 (.949-2.402) | |||
| Pleural effusion | .938 | ||||
| No | 49 | 1 | |||
| Yes | 54 | 1.018 (.654-1.538) | |||
| Neoadjuvant chemotherapy | .241 | ||||
| Yes | 77 | 1 | |||
| No | 27 | .713 (.405-1.256) | |||
| Operative type | .037 | .112 | 1.467 (.915-2.350) | ||
| Laparoscopic | 53 | 1 | |||
| Laparotomy | 51 | 1.633 (1.031-2.589) | |||
| Histological type | .971 | ||||
| Serous | 91 | 1 | |||
| Non-Serous | 13 | 1.013 (.499-2.059) | |||
| Residual massa | .226 | ||||
| ≤1 cm | 74 | 1 | |||
| >1 cm | 30 | 1.350 (.831-2.193) | |||
| Chemotherapy | <.001 | <.001 | 3.927 (1.875-8.226) | ||
| Complete | 93 | 1 | |||
| Incomplete | 11 | 3.928 (1.935-7.973) | |||
| Lung metastasis | .556 | ||||
| No | 92 | 1 | |||
| Yes | 11 | 1.248 (.597-2.607) | |||
| Liver metastasis | .231 | ||||
| No | 56 | 1 | |||
| Yes | 47 | 1.327 (.835-2.108) | |||
| Diaphragmatic angle lymph node metastasis | .497 | ||||
| No | 88 | 1 | |||
| Yes | 16 | 1.240 (.666-2.311) | |||
aResidual intra-abdominal foci.